EFEK PENYIMPANAN SEDIAAN PULVERES OBAT ANTI TUBERKULOSIS (OAT) ANAK TERHADAP KADAR RIFAMPISIN DAN ISONIASID
DOI:
https://doi.org/10.30595/pji.v9i2.703Abstract
ABSTRAK Dalam pengobatan TBC anak, dokter seringkali meresepkan obat anti tuberkulosis (OAT) anak secara kombinasi menjadi sediaan pulveres yang bertujuan untuk meningkatkan kepatuhan dan keteraturan minum obat. Tetapi, pengobatan dengan lebih dari satu macam jenis obat yang dikombinasikan menjadi satu bentuk sediaan tertentu dapat memicu terjadinya interaksi yang akan menimbulkan ketidakstabilan obat tersebut. Penelitian ini dilakukan dengan tujuan untuk menjajaki adanya perubahan stabilitas fisik dan penurunan kadar rifampisin dan isoniasid dalam sediaan pulveres racikan OAT selama penyimpanan pada suhu ruang. Jenis metode penelitian yang digunakan yaitu jenis eksperimental dengan rancangan penelitian one group pretest postest dan metode analisis data yang digunakan adalah one way anova. Selama penyimpanan 1 bulan stabilitas fisik sediaan pulveres OAT ini tidak mengalami perubahan yaitu serbuk kering, kemerahan dan bau khas . Tetapi, kadar rifampisin dan isoniasid yang merupakan komponen sediaan pulveres OAT mengalami penurunan. Kadar rata-rata penyimpanan rifampisin hari ke-0 sebesar 102,51%, hari ke-7 sebesar 101,88%, hari ke-14 sebesar 97,36%, hari ke-21 sebesar 95,19%, hari ke-28 sebesar 93,04%. Sedangkan, kadar rata-rata penyimpanan isoniasid hari ke-0 sebesar 104,66%, hari ke-7 sebesar 103,35%, hari ke-14 sebesar 94,55%, hari ke-21 sebesar 93,75%, hari ke-28 sebesar 92,69%. Hasil secara statistika menunjukkan adanya perbedaan signifikan (p<0.05). Kata kunci: pulveres, OAT, penyimpanan, rifampisin, isoniasid. ABSTRACT On the treatment of children with tuberculosis, doctor often prescribes anti-tuberculosis drug (OAT) for children in combination and make it pulveres preparation which is aimed to increase patient’s obedience and regularity in consuming medicine. However, the medication employing more than one form of drugs which was combined into one form of certain preparation may trigger instability of the drugs itself. This research was aimed to determine the changes of physical stability and the decreasing level of rifampin and isoniasid in pulveres preparation of OAT mixture during the storage on room temperature. The method employed in this research was experimental with one group pretest posttest research proposal and the data analysis method was one way anova. During one-month storage, there were no changes on the physical stability of OAT pulveres preparation i.e. it remained dry, reddish, and distinctive smell. However, the level of rifampin and isoniasid which was the component of pulveres preparation of OAT decreased. The average level of rifampin storage on day zero was 102.51%; day 7 was101.88%; day 14 was97.36%, day 21 was95.19%, day 28 was 93.04%. Whereas, the average level of isoniasid storage on day zero was104.66%; day 7 was103.35%; day 14 was94.55%; day 21 was 93.75%; day 28 was 92.69%. The statisticresult showed that there was a significant distinction(p<0.05). Keywords : pulveres, OAT, storage, rifampin, isoniasidReferences
, 2007, USP, United States
Chuluq, Chusnul, Achmad Ar, Abijoso, Bambang Shidharta, 2004, Pengembangan Paket SOT (sediaan obat tunggal) untuk Pengobatan Tuberkulosa Volume 32 No. 3 hal 127 – 134, Buletin Penelitian Kesehatan
Depkes RI, 1995, Farmakope Indonesia edisi 4, Jakarta, Depkes RI
Redelinghuys, A, M, 2006, Quality Specifications for Antituberculosis Fixed Dose Combination Products [thesis], Potchefstroom Campus of The North-West University
Singh, S., Bhutani, Mariappan, 2006, Quality Problems of Anti-Tuberculosis Fixed-Dose Combinations (FDCS, a Way Forward, India
UI, 1985, Ilmu Kesehatan Anak edisi 2, Jakarta, UI press
Downloads
Published
2012-08-01
How to Cite
Sari, L. N., Rahayu, W. S., & Astuti, I. Y. (2012). EFEK PENYIMPANAN SEDIAAN PULVERES OBAT ANTI TUBERKULOSIS (OAT) ANAK TERHADAP KADAR RIFAMPISIN DAN ISONIASID. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 9(02). https://doi.org/10.30595/pji.v9i2.703
Issue
Section
PHARMACY
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
